Teva Pharmaceutical Industries | TEVA - Interest Expense On Debt

Stock Price
9,330.00
Daily Change
91.00 0.99%
Monthly
-7.26%
Yearly
76.54%
Q2 Forecast
9,052.90

Teva Pharmaceutical Industries reported $220M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Cipla INR 140.3M 8.5M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Guangzhou Baiy CNY 102.39M 780K Jun/2025
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kalbe Farma IDR 9.69B 689.63M Sep/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025